Skip to content

Plaintiffs Seek Preliminary Approval of $1.51 Billion Settlement With Syngenta

Ridgefield Park, N.J. – Today plaintiffs, in the litigation against Syngenta related to its marketing and commercialization of Agrisure Viptera and Agrisure Duracade corn seeds, filed a motion for preliminary approval of a settlement with Syngenta before the United States District Court in the District of Kansas (MDL no. 2591). The settlement with Syngenta was reached in September of 2017 […]

March 12, 2018

Settlement With Syngenta

Ridgefield Park, N.J. – Today plaintiffs, in the litigation against Syngenta related to its marketing and commercialization of Agrisure Viptera and Agrisure Duracade corn seeds, filed a motion for preliminary approval of a settlement with Syngenta before the United States District Court in the District of Kansas (MDL no. 2591).

The settlement with Syngenta was reached in September of 2017 and finalized on February 23, 2018. The terms of the settlement were agreed upon only after years of hard fought litigation and negotiations between Syngenta and various plaintiff groups. If the settlement is approved, Syngenta will contribute $1.51 billion dollars to a settlement fund that would be used to make payments to be allocated among eligible corn farmers, grain handling facilities and ethanol production facilities who fall within the settlement class and to cover the costs of administering the settlement, including any court-approved award of fees to plaintiffs’ counsel, in exchange for a classwide release of all claims against Syngenta related to the launch of Agrisure Viptera and Agrisure Duracade. The $1.51 billion dollar settlement will resolve thousands of pending cases against Syngenta. The settlement does not constitute an admission by either side concerning the merits of the parties’ allegations and defenses.

If preliminary approval is granted, plaintiffs’ lawyers will begin notifying potential claimants about the settlement and how to submit a claim for compensation. The amount received by any individual claimant will vary depending on the individual claimant’s farming, grain handling, or ethanol production operations and will be determined through a claims process.

Plaintiffs are pleased with the settlement and look forward to the Court granting preliminary approval so next steps can be communicated to corn farmers and others eligible for compensation.

Seeger Weiss partner Chris Seeger served as a court-appointed member of the Plaintiffs’ Settlement Committee and Stephen Weiss served as a member of the Plaintiffs’ Executive Committee. Seeger and Weiss were accompanied in their efforts by partner Dion Kekatos, who was centrally involved in the multidistrict litigation and settlement briefing.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.

Read the full press release here.

Related News

March 14, 2023
Seeger Weiss Obtains $10 Million Settlement In Whistleblower Lawsuit Against Medical Device Company Stimwave

New York, NY– Today, the Department of Justice announced a $10 million settlement with Florida-based medical device company Stimwave, and a criminal indictment charging former CEO Laura Perryman in connection with a scheme to create and sell a non-functioning dummy medical device for implantation into patients suffering from chronic pain.  The scheme resulted in millions […]

Read More
February 28, 2023
Eleven Seeger Weiss Partners Selected For Lawdragon 500 Leading Plaintiff Consumer Lawyers List

Seeger Weiss is proud to announce that eleven of the firm’s partners were selected for Lawdragon 500 Leading Plaintiff Consumer Lawyers list for 2023. This list celebrates attorneys who are “tenacious advocates and dogged pursuers of justice,” a description fitting for these accomplished members of the Seeger Weiss team. Founding partners Chris Seeger and Stephen […]

Read More
February 9, 2023
Former NFL Players File Class Action Lawsuit Against NFL Disability Plans, Board, Commissioner Roger Goodell For Systemic Bias Against Disabled Players

New data suggest “neutral” NFL-hired doctors who deny more claims receive higher compensation. Baltimore, MD – Former NFL players today filed a class action lawsuit against The NFL Player Disability & Survivor Benefit Plan and NFL Player Disability & Neurocognitive Benefits Plan (the Plan), the Disability Board that administers the Plan, and each of the […]

Read More